HARTFORD, Conn. — In Hartford on Friday, state leaders announced a $58.6 million investment in the fight against the opioid ...

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

Of the 50 different drugs approved by the U.S ... which allows other pharmaceutical companies to produce biosimilars that are often less expensive and may even exhibit superior properties than ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on Rijnberk InvestInsights’ Substack by Daan Rijnberk.

Rather, several market forces explain why pharmaceutical companies are gradually abandoning ... In 1955 doctors bought the polio vaccine for $1.50 per dose and sold it to their patients for ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal ...

Today's pharmaceutical market is facing the challenges of inflation, government-imposed drug price caps and waning demand for ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...